BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bergantini L, Cameli P, d’Alessandro M, Vagaggini C, Refini R, Landi C, Pieroni M, Spalletti M, Sestini P, Bargagli E. NK and NKT-like cells in granulomatous and fibrotic lung diseases. Clin Exp Med 2019;19:487-94. [DOI: 10.1007/s10238-019-00578-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Rana GD, d'Alessandro M, Rizzi L, Bergantini L, Cameli P, Vozza A, Sestini P, Suppressa P, Bargagli E. Clinical phenotyping in sarcoidosis management. Sarcoidosis Vasc Diffuse Lung Dis 2021;38:e2021007. [PMID: 34316252 DOI: 10.36141/svdld.v38i2.10423] [Reference Citation Analysis]
2 Bergantini L, d'Alessandro M, Cameli P, Otranto A, Finco T, Curatola G, Sestini P, Bargagli E. Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases. Clin Immunol 2021;230:108827. [PMID: 34428741 DOI: 10.1016/j.clim.2021.108827] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jabbari P, Sadeghalvad M, Rezaei N. An inflammatory triangle in Sarcoidosis: PPAR-γ, immune microenvironment, and inflammation. Expert Opin Biol Ther 2021;:1-9. [PMID: 33798017 DOI: 10.1080/14712598.2021.1913118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bargagli E, Refini RM, d'Alessandro M, Bergantini L, Cameli P, Vantaggiato L, Bini L, Landi C. Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis. Int J Mol Sci 2020;21:E5663. [PMID: 32784632 DOI: 10.3390/ijms21165663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 d'Alessandro M, Bergantini L, Cameli P, Pieroni M, Refini RM, Sestini P, Bargagli E. Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy. Cancers (Basel) 2021;13:689. [PMID: 33572070 DOI: 10.3390/cancers13040689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 d'Alessandro M, Bergantini L, Perrone A, Cameli P, Cameli M, Prasse A, Plataroti D, Sestini P, Bargagli E. Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor. Eur J Intern Med 2020;78:58-62. [PMID: 32307232 DOI: 10.1016/j.ejim.2020.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 d'Alessandro M, Bergantini L, Cameli P, Mezzasalma F, Refini RM, Pieroni M, Sestini P, Bargagli E. Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers. Clin Exp Immunol 2021;205:406-16. [PMID: 34107064 DOI: 10.1111/cei.13635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang H, Costabel U, Dai H. The Role of Diverse Immune Cells in Sarcoidosis. Front Immunol 2021;12:788502. [PMID: 34868074 DOI: 10.3389/fimmu.2021.788502] [Reference Citation Analysis]
9 Bergantini L, d'Alessandro M, Cameli P, Cavallaro D, Gangi S, Cekorja B, Sestini P, Bargagli E. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19. Cells 2021;10:3182. [PMID: 34831404 DOI: 10.3390/cells10113182] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 d'Alessandro M, Bergantini L, Torricelli E, Cameli P, Lavorini F, Pieroni M, Refini RM, Sestini P, Bargagli E. Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series. Cancers (Basel) 2021;13:539. [PMID: 33572642 DOI: 10.3390/cancers13030539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Sun S, Huang C, Leng D, Chen C, Zhang T, Lei KC, Zhang XD. Gene fusion of IL7 involved in the regulation of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2021;15:1753466621995045. [PMID: 33878985 DOI: 10.1177/1753466621995045] [Reference Citation Analysis]
12 Lee S, Birnie D, Dwivedi G. Current perspectives on the immunopathogenesis of sarcoidosis. Respir Med 2020;173:106161. [PMID: 32992264 DOI: 10.1016/j.rmed.2020.106161] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kullberg S, Rivera NV, Grunewald J, Eklund A. Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis. BMJ Open Respir Res 2021;8:e000933. [PMID: 34233893 DOI: 10.1136/bmjresp-2021-000933] [Reference Citation Analysis]
14 d'Alessandro M, Bergantini L, Cameli P, Lanzarone N, Perillo F, Perrone A, Bargagli E. BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. Life Sci 2020;256:117995. [PMID: 32574666 DOI: 10.1016/j.lfs.2020.117995] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Bergantini L, d'Alessandro M, Cameli P, Perrone A, Cekorja B, Boncompagni B, Mazzei MA, Sestini P, Bargagli E. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases. Eur J Intern Med 2021;89:76-80. [PMID: 33931268 DOI: 10.1016/j.ejim.2021.04.005] [Reference Citation Analysis]
16 Vakrakou AG, Kolilekas L, Lama N, Katsanos S, Stratakos G, Tsougos I, Manali E, Grigoriou E, Psarra K, Kilidireas C, Papiris S, Kelekis NL, Gialafos EJ. Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvement. Eur J Clin Invest 2022;:e13742. [PMID: 35037712 DOI: 10.1111/eci.13742] [Reference Citation Analysis]
17 Zhang M, Zhang S. T Cells in Fibrosis and Fibrotic Diseases. Front Immunol 2020;11:1142. [PMID: 32676074 DOI: 10.3389/fimmu.2020.01142] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
18 d'Alessandro M, Bergantini L, Cameli P, Fanetti M, Alderighi L, Armati M, Refini RM, Alonzi V, Sestini P, Bargagli E. Immunologic responses to antifibrotic treatment in IPF patients. Int Immunopharmacol 2021;95:107525. [PMID: 33714885 DOI: 10.1016/j.intimp.2021.107525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Bergantini L, d'Alessandro M, De Vita E, Perillo F, Fossi A, Luzzi L, Paladini P, Perrone A, Rottoli P, Sestini P, Bargagli E, Bennett D. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution. Cells 2021;10:780. [PMID: 33916034 DOI: 10.3390/cells10040780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Bergantini L, d'Alessandro M, Vietri L, Rana GD, Cameli P, Acerra S, Sestini P, Bargagli E. Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases. Immunol Res 2020;68:414-21. [PMID: 33089426 DOI: 10.1007/s12026-020-09158-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
21 Shi L, Fu Q, Chen N, Liu R, Zheng Y. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease. Clin Exp Med 2020;20:393-9. [PMID: 32253547 DOI: 10.1007/s10238-020-00623-6] [Reference Citation Analysis]
22 Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects. Front Immunol 2020;11:1443. [PMID: 32760396 DOI: 10.3389/fimmu.2020.01443] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
23 d'Alessandro M, Carleo A, Cameli P, Bergantini L, Perrone A, Vietri L, Lanzarone N, Vagaggini C, Sestini P, Bargagli E. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases. Clin Exp Med 2020;20:207-16. [PMID: 31970550 DOI: 10.1007/s10238-020-00608-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
24 Bergantini L, d'Alessandro M, Cameli P, Bono C, Perruzza M, Biagini M, Pini L, Bigliazzi C, Sestini P, Dotta F, Bargagli E. Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab. Scand J Immunol 2021;94:e13031. [PMID: 33606277 DOI: 10.1111/sji.13031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]